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Abstract
Parkinson’s disease is characterized by a progressive degeneration of substantia nigra (SN)
dopaminergic neurons with age. We previously found that a single systemic lipopolysaccharide
(LPS, 5 mg/kg, i.p.) injection caused a slow progressive loss of tyrosine hydroxylase
immunoreactive (TH+IR) neurons in SN associated with increasing motor dysfunction. In this
study, we investigated the role of NADPH oxidase (NOX) in inflammation-mediated SN
neurotoxicity. A comparison of control (NOX2+/+) mice with NOX subunit gp91phox-deficient
(NOX2−/−) mice 10 months after LPS administration (5 mg/kg, i.p.) resulted in a 39% (p<0.01)
loss of TH+IR neurons in NOX2+/+ mice, whereas, NOX2−/− mice did not show a significant
decrease. Microglia (Iba1+IR) showed morphological activation in NOX2+/+ mice, but not in
NOX2−/− mice at 1 hour. Treatment of NOX2+/+ mice with LPS resulted in a 12 fold increase in
NOX2 mRNA in midbrain and 5.5–6.5 fold increases in NOX2 protein (+IR) in SN compared to
the saline controls. Brain reactive oxygen species (ROS), determined by hydroethidine
histochemistry, was increased by LPS in SN between 1 hour and 20 months. Diphenyliodonium
(DPI), a NOX inhibitor, blocked LPS-induced activation of microglia and production of ROS,
TNFα, IL-1β, and MCP-1. Although LPS increased microglial activation and ROS at all ages
studied, saline control NOX2+/+ mice showed age-related increases in microglial activation, NOX
and ROS levels at 12 and 22 months of age. Together, these results suggest that NOX contributes
to persistent microglial activation, ROS production and dopaminergic neurodegeneration that
persist and continue to increase with age.
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Parkinson’s disease (PD) is a neurodegenerative movement disorder common in the elderly
with most cases occurring after the age of 50. The loss of movement in PD is associated
with a progressive loss of dopaminergic neurons in the substantia nigra (SN). Increasing
evidence has demonstrated that neuroinflammation is a prominent contributor to the
pathogenesis of progressive PD (Block and Hong 2007; Hirsch and Hunot 2009; McGeer et
al. 2001; Qian et al. 2010). Previously, we reported that a single systemic injection of LPS
produced a persistent neuroimmune response that over months resulted in a loss of SN
neurons (Qin et al. 2007) and that LPS induced progressive SN neurodegeneration was
associated with motor function deficits reversible with L-DOPA (Liu et al. 2008; Qin et al.
2007). Our findings suggest that initial microglial activation amplifies glial neuroimmune
responses resulting in persistent increases in innate immune gene expression, e.g.
proinflammatory cytokines, oxidases and proteases (Qin et al. 2008; Qin et al. 2007). In this
report we test the hypothesis that NADPH oxidase (NOX), specifically (NOX2), contributes
to persistent microglial activation, reactive oxygen species (ROS) formation and SN
neurodegeneration.
NADPH oxidase (NOX) is a series of enzymes that are involved in producing ROS. The
most studied NOX enzyme, NOX2, also known as gp91phox, and phagocyte oxidase
(PHOX) is highly expressed in innate immune cells including microglia. Innate immune
gene induction in brain involves positive loops of proinflammatory gene induction that
converge upon the transcription factor NF-κB. NF-κB transcription is activated by kinases
as well as ROS (Crews et al. 2011). ROS has long been recognized as a contributor to
chronic progression of neurodegenerative diseases (Dauer and Przedborski 2003; Glass et al.
2010). Chronic neurodegenerative diseases, including Parkinsonism, occur primarily in the
elderly suggesting age and/or time contribute to disease progression. Studies in mixed
neuronal-glial cultures have found that NOX2 contributes to ROS formation, microglial
activation and dopamine (DA) neuron degeneration (Gao et al. 2003; Qin et al. 2004).
However, how NOX2 contributes to degeneration in vivo is poorly understood. To better
understand the interaction of microglial activation, NOX and neurodegeneration, we
investigated mice at various times during increasing age following lipopolysaccharide (LPS)
induced neuroimmune activation of microglia and NOX2 induction. We report here that
NOX2 contributes to the initiation and persistence of microglial activation and ROS
formation for months that contributes to SN neurodegeneration. Increasing age is further
found to increase microglial activation morphology, NOX2 expression and ROS formation.
The combination of persistent LPS neuroimmune activation and increasing age amplifies
ROS accelerating age related neurodegeneration. These studies suggest that NOX2 makes an




Eight-week-old male (25–30 g) and female (25–30 g) B6.129S6-Cybbtm1Din (NOX2−/−) and
C57BL/6J 000664 (NOX2+/+) mice were purchased from Jackson Laboratories (Bar Harbor,
ME). B6.129S6-Cybbtm1Din NOX2−/− mice lack a functional gp91 protein, an X
chromosome gene that contains the catalytic subunit of the NOX complex. The NOX2−/−
mutation is maintained in the C57BL/6J background; therefore, C57BL/6J (NOX2+/+) mice
were used as control animals. Breeding of the mice was performed to achieve eight-week-
old animals. Male mice were randomly assigned to different groups and treated according to
each group protocol. All protocols in this study were approved by the Institutional Animal
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Care and Use Committee and were in accordance with the National Institute of Health
regulations for the care and use of animals in research.
Reagents
Lipopolysaccharide (LPS, strain O111:B4) was purchased from Calbiochem (San Diego,
CA). Hydroethidine was from Invitrogen Molecular Probes (Eugene, OR). TNFα, IL-1β and
MCP-1 ELISA kits were purchased from R & D Systems Inc. (Minneapolis, MN). All other
reagents came from Sigma Chemical Co. (St. Louis, MO). Antibodies used in this study are
shown in Table 1.
Animal treatment
Male C57BL/6J (NOX2+/+) and Cybb (NOX2−/−) mice were intraperitoneally injected with
a single dose of LPS (5 mg/kg) or vehicle (0.9% saline). The dosage of LPS used (5 mg/kg,
i.p.) was based on our previous study of endotoxic shock and the loss of dopaminergic
neurons (Li et al. 2005). Mice were sacrificed at the time points indicated and brains were
used for mRNA, protein, and morphological analyses. For NOX inhibitor studies, male
C57BL/6 mice were treated with LPS (5 mg/kg, i.p.) or saline. Diphenyleneiodonium (DPI,
3 mg/kg) was injected intraperitoneally on two consecutive days 2 months after LPS
treatment. Mice were sacrificed 3 hr after the last dose of DPI. Brains were used for protein
and morphological study. Procedures using laboratory animals were in accordance with the
National Institutes of Health guidelines for the use of live animals and approved by IUCAC
boards.
Analysis of neurotoxicity
The loss of dopaminergic neurons was assessed by counting the number of TH
+immunoreactive (TH+IR) neurons in the substantia nigra pars compacta (SNpc) region by
2 individuals who were blind to the treatment using the CAST stereological system. The
boundary between the SNpc and the adjacent ventral tagmental area was defined using
(Paxinos and Franklin 2004). To ensure the accuracy of the count, a normal distribution
(rostral to caudal) of SNpc TH+IR neurons was first established in the control mice (Zhang
et al. 2004). In brief, we determined the number of SNpc TH+IR neurons for each of the 24
consecutive coronal sections that encompass the entire SN. Counts from 4 animals for each
sham-control group of NOX2+/+ and NOX2−/− mice were averaged to create a normal
distribution curve. No significant differences were observed in the distribution patterns for
SNpc TH+IR neurons between NOX2+/+ and NOX2−/− mice. A change in SN size could
lead to an underestimation of cell death, although our studies did not detect a global loss of
SN size. To count the number of SNpc TH+IR neurons in the saline and LPS-injected mice,
we used the first (rostral) and every forth section of the 24 sections of each brain (i.e., 8
sections/brain) for the counting. The distribution of the SNpc TH+IR neurons in each set of
brain sections was compared with that of its respective sham-control to correct for potential
“frame-shifting” errors resulting from brain slicing and assignment of the first of the 24
sections. A mean value for the number of SNpc TH+IR neurons was then deduced by
averaging the counts of the 8 sections for each animal; the results were expressed as the
average number of SNpc TH+IR neurons per section as described previously (Zhang et al.
2004)
Microscopic quantification
Two quantification methods were used to measure levels of immunostaining and fluorescent
staining. 1. Intensity of NOX2 immunoreactivity and ethidium fluorescence was measured
by BioQuant image analysis software (Nashville, TN). Images were captured on an
Olympus BX51 microscope and Sony DCX-390 video camera at 40X. Light levels were
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normalized to preset levels and the microscope, camera, and software were background
corrected to ensure reliability of image acquisition (Crews et al. 2004). Eight random images
from each brain section were captured within the substantia nigra (SN), the intensity of
immunostaining and fluorescence was measured in pixels within this area and expressed as
pixels/mm2. Subsequently, the average of the eight measurements was used to represent the
intensity of immunoreactivity or fluorescence of each section. Six sections were measured
per animal. When measuring the intensity of NOX2+IR and ethidium fluorescence in the
cells, we eliminated the background by adjusting threshold to avoid background staining. 2.
Number of TH+IR and Iba1+IR cells was counted using a modified stereological technique
in the substantia nigra pars compacta (SNpc) of immunostained brain sections using the
CAST stereological system (Chen et al. 1998; McClain et al. 2011; Qin and Crews 2012a).
For confocal microscopy, triple labeled sections were digitally photographed with Leica
SP2-AOBS confocal microscope and analyzed with Leica SP2 LCS software.
Immunohistochemistry
Brains were fixed in 4% paraformaldehyde and processed for immunostaining as described
previously (Qin et al. 2004). Dopaminergic neurons were detected with the polyclonal
antibody against TH. Microglia were stained with rabbit anti-Iba1 antibody. NADPH
oxidase membrane subunit gp91phox (NOX2) was immunostained with monoclonal anti-
mouse gp91phox antibody. Astroglia were stained with polyclonal rabbit anti-glial fibrillary
acidic protein (GFAP). Immunostaining was visualized by using 3,3′-diaminobenzidine
(DAB) and urea-hydrogen peroxide tablets or nickel-enhanced DAB or Alexa Fluor 488
(green) and 555 (red) dye.
In situ visualization of O2− and O2− - derived oxidant production
In situ visualization of O2− and O2− - derived oxidant (ROS) production was assessed by
hydroethidine histochemistry (Bindokas et al. 1996; Wu et al. 2003). Mice were injected
with hydroethidine (10 mg/kg, i.p.) in 0.5% carboxymethyl cellulose at the time points
indicated. Brains were harvested 30 min later and frozen sections (15 μm) were examined
for hydroethidine oxidation product, ethidium accumulation, and fluorescence microscopy
(excitation 510 nm; emission 580 nm).
Real-time RT-PCR analysis
Total RNA was extracted from the mouse midbrain samples 24 hr after LPS or saline
treatment and used for reverse transcription PCR analysis as described previously (Qin et al.






Mouse gp91phox (NOX2) 5′-CAGGAGTTCCAAGATGCCTG-3′
5′-GATTGGCCTGAGATTCATCC-3′
Mouse β-actin 5′-GTA TGA CTC CAC TCA CGG CAA A-3′
5′-GGT CTC GCT CCT GGA AGA TG-3′
The SYBR green DNA PCR kit (Applied Biosystems, Foster City, CA) was used for real-
time PCR analysis. The relative differences in expression between groups were expressed
using cycle time (Ct) values normalized with β-actin, and relative differences between
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control and treatment group were calculated and expressed as relative increases setting
control as 100%.
TNFα, IL-1β and MCP-1 assay
Frozen brains were homogenized in 100 mg tissue/ml cold lysis buffer (20 mM Tris, 0.25M
sucrose, 2 mM EDTA, 10 mM EGTA, 1% Triton X-100) and 1 tablet of Complete Mini
protease inhibitor cocktail tablets/10 ml (Roche Diagnostics, Indianapolis, IN). Samples
were centrifuged at 100,000 × g for 40 min. Supernatant was collected for protein assay
using the BCA protein assay reagent kit (PIERCE, Milwaukee, WI). The levels of TNFα,
IL-1β and MCP-1 in brains were measured with mouse TNFα, IL-1β and mouse JE/MCP-1
commercial enzyme-linked immunosorbent assay (ELISA) kits from R&D Systems
(Minneapolis, MN), as described previously (Gu et al. 1998).
Statistical analysis
The data are expressed as the mean ± SEM and statistical significance was assessed with an
ANOVA followed by Bonferroni’s t-test. A value of P < 0.05 was considered statistically
significant.
RESULTS
NOX2 contributes to systemic LPS-induced loss of dopaminergic neurons in the
substantia nigra
To investigate the role of NOX-generated ROS in LPS-induced neurodegeneration,
NOX2+/+ and NOX2−/− mice were injected intraperitoneally with LPS (5 mg/kg) or saline.
The brains were removed 10 months after LPS treatment, and coronal sections that
encompass the entire SN were taken. The sections were immunostained with an antibody
against TH to detect dopaminergic neurons in substantial nigra pars compacta (SNpc).
Immunohistochemical analysis for TH immunoreactivity (+IR) indicated that systemic LPS
injection caused a 39% (p<0.01) loss of TH+IR neurons in the SN of NOX2+/+ mice 10
months after LPS (12 months old) compared to age matched saline controls (Fig. 1).
Transgenic NOX−/− 12 month old control mice had similar levels of TH+IR neurons in SN
to NOX2+/+control mice, however TH+IR neurons in the SN of LPS treated NOX2−/−
mutants were decreased 11%, which was not statistically different from either control
groups. These findings suggest that NOX contributes to degeneration of dopaminergic
neurons in the SN.
NOX2 mediates microglial activation in response to systemic LPS administration
Microglia initiate neuroimmune responses in brain and contribute to amplification of
proinflammatory responses associated with morphologically distinct stages of activation
(Block and Hong 2005; Block and Hong 2007; Crews et al. 2011). We investigated Iba1, a
specific marker for microglia and other monocyte-like cells. Although Iba1 expression is
increased during activation, Iba1+IR labels all microglia regardless of activation state
allowing morphological assessments of activation (Ito et al. 1998). Iba1 mRNA was
significantly upregulated about 2.5 fold in NOX2+/+ mice, but not in NOX2−/− mice (Fig.
2A). Microglia Iba1+IR morphology, an indicator of microglia activation state, found
Iba1+IR cells in 2 month old NOX2+/+ and NOX2−/− mice injected with saline had small
cell bodies with thin, highly ramified processes, consistent with the morphology of resting
microglia. However, Iba1+IR morphology in NOX2+/+ mice injected with LPS (5 mg/kg,
i.p.) displayed the characteristics of activated amoeboid microglia, increased cell bodies,
irregular shape, and intensified Iba1+IR. Human brain microglia from subjects with sepsis
show similar Iba1+IR cytoplasmic hypertrophy characteristic of activated microglia (Streit
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et al. 2009). In contrast, LPS activation of microglia was significantly less pronounced in the
SN of NOX2−/− mice (Fig. 2B). In addition, LPS induction of brain TNFα mRNA was
blunted (i.e. 134±13 and 80±7 fold (p<0.01) in NOX2+/+ and NOX2−/− mice, respectively
(data not shown). Interestingly, LPS induced serum TNFα was almost identical between
NOX2+/+ and NOX2−/− mice suggesting our high dose intraperitoneal LPS activated TNFα
release from gut-blood monocytes, and/or other cells that increase blood TNFα that are not
impacted by NOX2 (Supplementary Fig. 1). The reduced induction of Iba1 and TNFα
mRNA and microglial activation morphology in NOX2−/− mice further support an important
role for NOX in activation of microglia, a key initial step in neuroimmune activation and
neurodegeneration.
Microglial morphology defined activation states provides an index of neuroimmune
activation in models of neurodegeneration. We investigated the long term impact of LPS
treatment at multiple points up to 10 months after LPS treatment in NOX2+/+ mice (Fig. 3).
LPS treatment of 2 month old NOX2+/+ mice resulted in a rapid increase in activated
morphology Iba1+IR cells within 1 hr that persisted at 24 hr. In the saline control groups,
microglia at 1, 3, and 24 hr have a resting morphology, small cell bodies with thin, highly
ramified processes. However, saline controls showed age-related increases in microglial
activation at 4, 9 and 12 months of age (Fig. 3). LPS treated mice showed greater numbers
of activated microglia for up to 10 months after LPS treatment, i.e. 4 to 12 months of age
(2–10 months after LPS) that paralleled saline control age-related increases in activated
microglial morphology. Interestingly, control mice at 12 months of age had similar levels of
activated microglia as LPS treated animals at 4 months of age (i.e. 2 months after LPS
treatment) (Fig. 3). These results indicate activation of brain microglia by LPS persists for
long periods that further increase in parallel with age related increases in microglial
activation.
Increased NOX expression and ROS production
We have previously found that NOX induction is associated with markers of neuronal death
in both mouse and human brain (Qin and Crews 2012b). NOX2 is a membrane subunit
(gp91phox) of NADPH oxidase (NOX), the enzyme complex responsible for the respiratory
burst of reactive oxygen species (ROS) that occurs in activated phagocytes. Activation of
this enzyme in microglia induces the production of ROS, resulting in dopaminergic
neurotoxicity in mixed glial-neuronal cultures (Qin et al. 2004). We determined NOX2
(gp91phox) mRNA and NOX2+IR cells in brain. Treatment of C57BL/6 mice with LPS
resulted in a 12 fold increase in NOX2 mRNA in midbrain at 24hr (Fig. 4A). NOX2+IR
cells are small and rare in controls. In LPS treated mice NOX2+IR cells were increased
about 5.5 fold in SN at 24hr (Fig. 4B), consistent with rapid induction of NOX2 mRNA and
protein. NOX2+IR cells include large and small phenotypes that likely include microglia
and other brain cell types. Interestingly, NOX2+IR cells increased at 10 and 20 months in
saline controls with some showing neuron-like morphology (4B, 4C). In LPS treated mice,
NOX2+IR cells also increased with age in parallel with saline controls. NOX2+IR cells
were 5.8 and 6.5 fold greater than age matched controls at 10 and 20 months, respectively.
NOX2+IR cells in SN 10 and 20 months after LPS show distinct neuron-like large triangular
morphology with processes (Fig. 4C). These findings indicate NOX induction increases
rapidly in brain following LPS treatment, and continues to increase with age through an
induction in neuron-like large cells as well as smaller glial cells.
NOX2 is the catalytic subunit of NADPH oxidase that produces superoxide that is linked to
ROS and oxidative stress. To investigate oxidative stress within mouse brain, we used a
histochemical method that allows in situ visualization of O2− and O2−-derived oxidant
production by dihydroethidium (DHE), a lipophilic ROS-sensitive dye that crosses the blood
brain barrier allowing localization of superoxide and other ROS in brain (Murakami et al.
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1998; Zielonka et al. 2009), although changes in the blood brain barrier might impact
responses. DHE is converted to fluorescent ethidium at the sites of formation of superoxide
and ROS. In 2 month old saline control mice, production of O2− and O2−-derived oxidants,
evidenced by ethidium fluorescence, was very low at 1h and 24hr. Aging saline control mice
showed increased age-related ethidium fluorescence (ROS) at 12 and 22 months of age (10
and 20 months after saline) (Fig. 5), compared with 2 month-old mice. LPS treatment
rapidly increased ROS production many fold at 1 and 24hr. At 1 hr both small and large
cells show red fluorescence with both cell phenotypes increasing by 24 hr. Both saline and
LPS treated mice show distinct red cellular phenotypes at 12 and 22 months of age (10 and
20 months after LPS). LPS treated animals 10 and 20 months after treatment show large
highly labeled sites larger than any single cell. Although LPS induced ROS fluorescent
intensity 24 hr after LPS only slightly increased over the next 10 months, ROS fluorescence
almost doubled as LPS treated mice aged from 12–22 months (i.e. 10–20 months after LPS)
(Fig. 5). These results indicate LPS causes persistent increases in ROS in SN that further
increase with age.
NOX and ROS cellular localization
To further investigate induction of NOX and production of ROS, we performed triple
immunohistochemistry using antibodies to gp91phox (NOX2) and Iba1, a microglial marker,
TH, a marker of dopaminergic neurons or GFAP, a marker of astrocytes on brain sections
from the mice injected with dihydroethidium 10 months after systemic LPS treatment. As
shown in figure 6A, TH+IR cells (green) show fragmented dysmorphology consistent with
degeneration. NOX gp91phox+IR cells (blue)and ROS (red) are triple-labeled with TH+IR
cells (green) that in the merged panel identifies overlapping blue-red-green cells as white.
We found that both TH, the dopaminergic neuron marker, and Iba1, the microglial marker
showed prominent overlap with NOX2 and ROS, but not with the astrocyte marker GFAP
+IR (green) as shown in Figure 6A and 6B. These results indicate that NOX expression and
ROS production predominantly occurred in microglia and dopaminergic neurons in the
substantia nigra 10 months after LPS treatment.
DPI suppresses microglial activation, ROS generation and production of proinflammatory
cytokines
To further investigate the role of NOX in neuroimmune activation, we studied
diphenyleneiodonium (DPI, 3 mg/kg, i.p.), a non-specific inhibitor of oxidases known to
block NOX, in 4 month old mice, 2 months after LPS treatment. Iba1+IR microglial
activated morphology were found in the LPS-treated group, however, in the LPS and DPI
co-treated group, Iba1+IR cells displayed resting morphology, similar to saline and DPI
alone (Fig. 7). Assessment of ethidium fluorescence (ROS) indicated as expected that DPI
treatment reduced ROS formation in LPS treated mice (Fig. 8A). Further, LPS treatment
caused long-lasting elevated levels of TNFα, IL-1β and MCP-1protein in mouse brain as
determined by ELISA. Among these proinflammatory cytokines, IL-1β remained increased
many fold 2 months after LPS treatment. DPI treatment significantly reduced TNFα, IL-1β
and MCP-1 protein in LPS treated mice (Fig. 8B). These data suggest that NOX activation
and persistent ROS are essential for persistent microglial activation and elevation of
proinflammatory cytokines.
DISCUSSION
We report here that the slow progressive LPS-induced loss of SN dopaminergic neurons in
vivo is blunted in NOX2−/− mice 10 months after LPS treatment. Further, LPS induced
microglial activation was reduced in NOX2−/− mice. We have previously found that LPS
induced brain TNFα persisted for at least 10 months in association with SN
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neurodegeneration (Qin et al. 2007). More extensive studies indicated a slow progressive SN
TH neuron loss, that after 7 months was significantly reduced by about 25% (Liu et al. 2008;
Qin et al. 2007). In female mice, resistant to SN TH loss, monthly LPS increased SN
degeneration and caused L-DOPA reversible motor dysfunction (Liu et al. 2008). In mice
microglial and NOX2 activation coincide with neuronal death that is blocked by NOX
inhibitors (Qin and Crews 2012b). We report here that DPI inhibition of ROS formation is
able to reverse microglial activation and elevated levels of proinflammatory cytokines
following two months of persistent activation. These results support the hypothesis that
activation of NOX and formation of ROS drive persistent brain microglial neuroimmune
activation, NOX2 induction and ROS formation that contribute to SN dopaminergic
neurodegeneration.
We studied microglial morphology at multiple ages from young adults (e.g. 2 months of
age) to elderly adults (e.g. 22 months of age) and found age related increases in microglial
activation, NOX2 expression and ROS production in both healthy controls and LPS treated
mice. LPS treated mice showed rapid increases in microglial activation morphology, NOX2
expression, and ROS formation within hours that persisted for days and months. Controls at
4 months of age began to show slight increases in microglial activation morphology that
increased with age such that 10 month saline control brain activated microglia were similar
to LPS treated mice at 4 months old. LPS treated animals also showed age related increases
in activation remaining persistently elevated, compared to age matched controls. Senescent
microglial activation morphology is confounded by dystrophic (Streit et al. 2009) and/or
acquired deactivation states (Colton 2009) that could contribute to our findings of age
related increases in microglial activation morphology. Regardless, our findings indicate that
LPS induced microglial activation persists for almost the entire lifespan of mice and could
underlie the increased incidence of neurodegenerative diseases with increasing age,
particularly PD.
Expression of NOX2 and production of ROS also increased with age at 12 and 22 months
(10 and 20 months after LPS). However, LPS treated mouse brains showed increasingly
greater increases in NOX2 and ROS with age compared to controls consistent with
acceleration and amplification of NOX2 oxidative stress with age. This differs from the
parallel increases in microglial activation with age from 4 to 22 months between control and
LPS groups. Interestingly, we found expression of NOX2 in 12 and 22 month old animals
appeared to increase primarily in large cells having neuron-like morphologies. Further, ROS
determinations found increasingly large ROS marked complexes in older animals of both
groups. Confocal microscopy using cell type specific markers found that TH+IR cells
colocalized with ROS and NOX2 (gp91) in brains of LPS treated mice 10 months after
treatment indicating oxidative stress is increasing within SN TH neurons (Fig. 6). Microglia
also showed co-localization with NOX2 and ROS. These findings are consistent with our
hypothesis that persistent neuroimmune activation involves ROS formed from NOX2 that
with increasing age results in amplified oxidative stress and SN TH neuron degeneration
(Fig. 9).
In summary, LPS increases SN NOX2 expression, ROS production and microglial activation
that persist for long periods and perhaps the lifetime. Age also leads to increases in
neuroimmune activation. LPS and age act synergistically in old mice, increasing NOX2
expression and ROS formation that likely contribute to increased SN neurodegeneration
during aging.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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NOX2-deficient mice are more resistant to systemic LPS-induced neurotoxicity. Eight-
week-old male C57BL/6 (NOX2+/+) and Cybb (NOX2−/−) mice were intraperitoneally
injected with a single dose of LPS (5 mg/kg, i.p.) or saline and then maintained under
normal conditions. Mice were sacrificed and brain sections (35 μm) that encompass the
entire substantia nigra (SN) were collected 10 months after LPS or saline injection. After
immunostaining with TH antibody, the number of TH+IR neurons in the substantia nigra
pars compacta (SNpc) was counted as described in methods. (A) Visualization of TH+IR
neurons in the substantia nigra (SN) of saline and LPS-treated animals. Scale bar=200 μM.
(B) Number of TH+IR neurons in the SN of saline and LPS-treated NOX2+/+ and NOX2−/−
mice. Systemic LPS injection caused a greater loss of TH+IR neurons in the SN of NOX2+/+
mice than that of NOX2−/− mice, compared with the corresponding saline controls. ** P <
0.01, compared with the corresponding saline controls.
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Immunocytochemical analysis of microglia. NOX2+/+ and NOX2−/− mice were sacrificed 1
hr following saline or LPS (5 mg/kg, i.p.). (A) Iba1 mRNA in midbrain was determined by
real-time PCR. Systemic LPS treatment significantly upregulated Iba1 gene expression in
NOX2+/+ mice, but not in NOX2−/− mice. (B) Brain sections were immunostained with an
antibody against Iba1, a specific microglial marker. Activated microglia in substantia nigra
were shown by increased cell size, irregular shape and intensified Iba1 staining in LPS-
treated NOX2+/+ mouse brains. The images presented are representative of three
independent experiments. Scale bar=50μM.
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Time course of microglial response to systemic LPS treatment. Male C57BL/6 mice were
injected with saline or LPS (5 mg/kg, i.p.) and sacrificed at the time points indicated. Brain
sections were immunostained with Iba1 microglial antibody. (A) Quantification of activated
Iba1+IR cells in substantia nigra. LPS groups at all the time points studied increased the
fraction of activated microglia with a peak at 3 hr. Age-related percent activated Iba1+IR
cells were significantly increased at 2, 7 and 10 months after saline injection (4, 9 and 12
months of age). (B) Representative images from saline and LPS-treated mice. LPS groups
showed persistent activation of microglia with the largest morphological changes at 3 hr. In
the saline control groups, microglia at 1, 3, and 24 hr have a resting morphology: small cell
bodies with thin, highly ramified processes. However, at 2, 7 and 10 months some microglia
were activated, large cell bodies, irregular shape and intensified Iba1 staining. *P<0.05,
**P<0.01, compared with the corresponding saline control group. ##P<0.01, compared with
1h saline group. Scale bar=50μm.
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Systemic LPS increases brain NOX2 expression. Male C57BL/6 mice were injected with
LPS (5 mg/kg, i.p.) or saline and sacrificed at 24 hr, 10 and 20 months following LPS
treatment. (A) NOX2 gene expression in the midbrain was determined by real-time PCR.
NOX2 mRNA was significantly increased 24 hr after LPS treatment. (B) Brain sections
were immunostained with monoclonal mouse NOX2 antibody, which did not stain NOX2−/−
mouse brain. The level of NOX2 immunoreactivity in SN was quantified by BioQuant
image analysis system. Systemic LPS significantly enhanced NOX2 immunoreactivity at 24
hr, 10 and 20 months. (C) The images shown are representative ofNOX2+IR cells from
control and LPS groups. Age-related NOX2 up-regulation was observed at 10 and 20
months in saline control mice. Scale bar=30μm. **P < 0.01, compared with the
corresponding saline control mice, #P<0.05, ##P<0.01, compared with 24 hr saline control
mice.
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Systemic LPS treatment induces ROS production at 1 and 24 hr and remains elevated at 10
and 20 months. Mice were injected with hydroethidine (10 mg/kg, i.p.) 0.5hr, 23.5 hr, 10
months and 20 months after a single i.p. injection of LPS. Brains were harvested 30 min
later and frozen sections (15μm) were examined for hydroethidine oxidation product,
ethidium accumulation, by fluorescence microscopy. (A) Level of fluorescence intensity of
ethidium was quantified by BioQuant image analysis software. (B) Images of ethidium
fluorescence. Systemic LPS treatment significantly induced O2− and O2−-derived oxidant
production (ROS) 1 and 24hr and remains elevated 10 and 20 months after LPS injection,
compared with the corresponding saline controls. Age-related ROS production was
enhanced at 10 and 20 months in saline control mice, ** P < 0.01, compared with the
corresponding saline control group. ## P< 0.01, compared with 1 hr saline group. Scale
bar=200 μM.
Qin et al. Page 15














Colocalization of NOX2 expression and ROS production. Mice were injected with
hydroethidine (10 mg/kg, i.p.) 10 months after a single dose of LPS i.p. injection. Brains
were harvested 30 min later and frozen sections (15 μm) were double-labeled for NOX2
(blue) and Iba1 (green), NOX2 (blue) and TH (green) as well as NOX2 (blue) and GFAP
(green) to analyze triple labeling or colabeling by using the Leica SP2 LCS confocal
software. Confocal microscopy shows that NOX2+IR cells and ROS are triple-labeled with
TH (A-merged, the right lower panel and B-merged, the left panel) or Iba1 (B-merged, the
middle panel) in white with arrows, indicating NADPH oxidase (NOX) subunit NOX2
(gp91phox) activation and ROS production predominantly occurred in DA neurons and
microglial cells. Conversely, NOX2+IR cells and ROS are little glial fibrillary acidic protein
(GFAP) positive. Double-labeled representative images are shown in pink with arrow heads
indicating the colabeling of NOX2 with ROS (A-merged, the right lower panel; B-merged,
the right panel). In Fig. 6A, Scale bar=30μm. In Fig. 6B, Scale bar=20μm.
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Diphenyleneiodonium (DPI) blocks LPS-induced microglial activation. Male C57BL/6 mice
were treated with LPS (5 mg/kg, i.p.) or saline. DPI (3 mg/kg) was injected intraperitoneally
on two consecutive days 2 months after LPS treatment. Mice were sacrificed 3 hr after the
last dose of DPI. Brain sections were stained with Iba1 antibody. Systemic LPS markedly
caused microglial activation. In the saline or DPI treated mice, most of the microglia were in
a resting morphological shape. Iba1+IR cells in LPS-treated mouse brains were activated as
shown by increased cell size, irregular shape, and intensified Iba1 staining. DPI blocked
LPS-induced microglial activation shown by a resting morphological shape. Scale
bar=50μm.
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Diphenyleneiodonium (DPI) inhibits LPS-induced production of ROS, TNFα, IL-1β, and
MCP-1. Male C57BL/6 mice were treated with LPS (5 mg/kg, i.p.) or saline. DPI (3 mg/kg)
was applied intraperitoneally on two consecutive days 2 months after LPS treatment. Mice
were sacrificed 3 hr after the last dose of DPI. Brain O2− and O2−-derived oxidants (ROS),
TNFα, IL-1β, and MCP-1 were measured as described in materials and methods. (A)
Representative images of O2− and O2−-derived oxidants in SN. DPI significantly reduced
LPS-induced production of O2− and O2−-derived oxidants. Scale bar=30μm. (B) Systemic
LPS treatment significantly increased production of TNFα, IL-1β, and MCP-1 compared
with saline controls. DPI significantly reduced LPS-induced increases in production of
TNFα, IL-1β, and MCP-1. * P < 0.05, compared with the saline control mice, #P < 0.05,
compared with the LPS-treated mice.
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NOX-ROS is a key signaling in systemic LPS-induced dopaminergic neurodegeneration.
LPS as a pro-inflammatory trigger activates microglia to release neurotoxic factors, such as
TNFα, IL-1β, MCP-1, and ROS (O2−). Among these pro-inflammatory factors, ROS have
been implicated as key mechanisms of LPS neurotoxicity. Further, damaged or dying
neurons have the potential to prime microglia to become more sensitive to additional stimuli
and result in an exaggerated and prolonged proinflammatory response that enhances
neuronal damage (i.e. reactive microgliosis). NOX2-deficient (NOX2−/−) mice showed
reduced DA neurotoxicity and decreased microglial activation. Blockade of NOX with DPI
inhibits activation of microglia and production of ROS, TNFα, IL-1β and MCP-1. These
results suggest that NOX and aging contribute to systemic LPS-elicited microglial
activation, oxidative stress and dopaminergic neurodegeneration.
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